Baird Financial Group Inc. Has $2.84 Million Holdings in Aspen Aerogels, Inc. $ASPN

Key Points

• Baird Financial Group Inc. increased its stake in Aspen Aerogels by 10.8%, acquiring an additional 43,149 shares to bring its total ownership to 444,280 shares, valued at approximately $2.84 million.
• Aspen Aerogels reported a quarterly revenue of $78.02 million, beating analyst estimates, though its quarterly revenue declined 33.8% year-over-year.
• The company's average analyst rating is "Moderate Buy", with a price target of $19.50, despite recent adjustments by firms like Canaccord Genuity and Barclays.

Baird Financial Group Inc. increased its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 10.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 444,280 shares of the construction company's stock after acquiring an additional 43,149 shares during the quarter. Baird Financial Group Inc. owned approximately 0.54% of Aspen Aerogels worth $2,839,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ASPN. Price T Rowe Associates Inc. MD boosted its holdings in shares of Aspen Aerogels by 38.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 42,451 shares of the construction company's stock valued at $505,000 after acquiring an additional 11,688 shares in the last quarter. Northern Trust Corp boosted its stake in Aspen Aerogels by 13.7% in the 4th quarter. Northern Trust Corp now owns 641,050 shares of the construction company's stock worth $7,616,000 after purchasing an additional 77,364 shares during the period. Ameriprise Financial Inc. lifted its position in Aspen Aerogels by 17.8% in the 4th quarter. Ameriprise Financial Inc. now owns 524,501 shares of the construction company's stock worth $6,231,000 after buying an additional 79,122 shares in the last quarter. BNP Paribas Financial Markets lifted its position in Aspen Aerogels by 645.4% in the 4th quarter. BNP Paribas Financial Markets now owns 135,584 shares of the construction company's stock worth $1,611,000 after buying an additional 117,395 shares in the last quarter. Finally, Deutsche Bank AG lifted its position in Aspen Aerogels by 37.0% in the 4th quarter. Deutsche Bank AG now owns 415,391 shares of the construction company's stock worth $4,935,000 after buying an additional 112,241 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on ASPN shares. Canaccord Genuity Group cut their price target on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Barclays lowered shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and raised their price target for the stock from $7.00 to $16.00 in a research report on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Aspen Aerogels has a consensus rating of "Moderate Buy" and an average target price of $19.50.

Insider Buying and Selling

In related news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total transaction of $32,237.10. Following the completion of the transaction, the chief accounting officer owned 19,879 shares in the company, valued at approximately $145,315.49. This represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 4.30% of the company's stock.

Aspen Aerogels Trading Down 2.9%

Shares of ASPN traded down $0.20 on Friday, reaching $6.60. 1,341,668 shares of the company's stock were exchanged, compared to its average volume of 1,438,317. The stock has a market capitalization of $543.58 million, a P/E ratio of -1.73 and a beta of 2.65. The business has a 50 day moving average price of $7.12 and a two-hundred day moving average price of $6.48. The company has a current ratio of 3.98, a quick ratio of 3.31 and a debt-to-equity ratio of 0.34. Aspen Aerogels, Inc. has a 12 month low of $4.16 and a 12 month high of $30.24.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.08. The company had revenue of $78.02 million during the quarter, compared to analysts' expectations of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The business's quarterly revenue was down 33.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. Research analysts anticipate that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.